DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
Life Science Division Executive Director and Head of Research Dr Navid Malik joins DirectorsTalk to discuss ImmuPharma plc (LON: IMM). Navid provides an overview of the Life Science Division and..
Hardide plc (LON: HDD) CEO Philip Kirkman joins DirectorsTalk to discuss it’s record revenues for the second consecutive year. Phil talks us through the highlights, explains how the customer and..
Palace Capital (LON: PCA) is the topic of conversation when Mike Foster, Analyst at Hardman & Co joins DirectorsTalk. Mike provides a little background on the company, talks us through..
Non-Standard Finance (LON: NSF) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains why NSF has had a severe share price reaction to..
Zenith Energy (LON: ZEN) CEO Andrea Cattaneo joins DirectorsTalk to discuss the acquisition of Coro Energy’s entire natural gas production and exploration portfolio in Italy. Andrea talks us through the..
ImmuPharma plc (LON: IMM) Non-Executive Chairman Tim McCarthy joins DirectorsTalk to discuss a licencing and development agreement with US speciality pharmaceutical company Avion. Tim talks us through the key highlights..
Gresham House Strategic (LON: GHS) Managing Director Graham Bird joins DirectorsTalk to discuss interim results. Graham talks us through the financial highlights, the investment management highlights, performance post period and..
Premier Miton Investors (LON: PMI) Head of Equities, Gervais Williams joins DirectorsTalk to discuss British Stocks and 2020’s Best Opportunity. Gervais shares his thoughts on Morgan Stanley strategist comments that..
Sativa Group (NEX: SATI) CEO Henry Lees-Buckley joins DirectorsTalk to discuss its latest update to the market. Henry explains how two new appointments will help to strengthen its position, updates..
Cambria Automobiles (LON: CAMB) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. Mike explains how the results compare with forecasts, the key..
CentralNic Group (LON: CNIC) Chief Executive Officer Ben Crawford chats to DirectorsTalk about it’s latest acquisition of Team Internet for $45m. Ben explains what Team Internet does and how it..
Touchstone Exploration (LON: TXP) CEO Paul Baay joins DirectorsTalk to discuss test results at the COHO 1 well in Trinidad and Tobago. Paul talks us through the results, explains what’s..
TT Electronics plc (LON: TTG) CEO Richard Tyson joins DirectorsTalk to discuss its trading update to the end of October 2019. Richard explains why he is happy with the level..
NQ Minerals Plc (NEX: NQMI) (OTCQB: NQMLF) new Chairman David Lenigas joins DirectorsTalk to discuss his new role. David explains why he has joined the company, what investors can expect..
Avacta Group (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to update us on the collaboration with LG Chem. Alastair reminds investors of the details behind the collaboration, updates us on..
Jubilee Metals Group (LON: JLP) CEO Leon Coetzer joins DirectorsTalk to discuss it’s audited results for the year ended 30th June 2019. Leon gives an overview of the results, explains..
Advanced Oncotherapy plc (LON: AVO) is the topic of conversation when Dr Martin Hall, Head of Life Sciences at Hardman & Co joins DirectorsTalk. Martin talks us through some interesting..
Morses Club plc (LON: MCL) are the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains what was learnt from the recent results, details on..
Maestrano Group plc (LON: MNO) CEO Andrew Pearson joins DirectorsTalk to discuss the acquisition of Airsight Holdings. Andrew explains the new company business model, provides details on around the acquisition..
Arbuthnot Banking Group (LON: ARBB) are the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains what was said in the October statement, how new..
